PAR 0.00% 22.5¢ paradigm biopharmaceuticals limited..

Resolution of lumbar bone marrow oedema, page-74

  1. 4,433 Posts.
    lightbulb Created with Sketch. 6996
    Denial - Yes, mentioned:


    "Preferably, the mammal is suffering from an arthritic condition. The arthritic condition is preferably selected from rheumatoid arthritis or osteoarthritis. Preferably, the arthritic condition is rheumatoid arthritis. Preferably, the arthritic condition is osteoarthritis. Preferably, the osteoarthritis is in an articulating joint selected from the group consisting of: an ankle, a hip, knee, shoulder, spine and wrist. The osteoarthritis is preferably in the knee. Preferably, the osteoarthritis is in the spine (spondylosis)."



    ..and further (in a few places in the doc) ...

    " The use according to example embodiment 31, wherein the osteoarthritis is in the spine (spondylosis). "






    Ref: https://patentscope.wipo.int/search/en/detail.jsf?docId=AU368914118&_cid=P21-LJ5LNR-53391-22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.000(0.00%)
Mkt cap ! $78.73M
Open High Low Value Volume
23.0¢ 23.0¢ 21.5¢ $78.13K 350.8K

Buyers (Bids)

No. Vol. Price($)
2 64880 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 43479 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.